Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
Background: Diagnosis of AF-induced cardiomyopathy can be challenging and relies on ruling out other causes of cardiomyopathy and, after restoration of sinus rhythm, recovery of left ventricular (LV) function. The aim of this study was to identify clinical and echocardiographic predictors for develo...
Guardado en:
Autores principales: | Erez Marcusohn, Ofer Kobo, Maria Postnikov, Danny Epstein, Yoram Agmon, Lior Gepstein, Yaron Hellman, Robert Zukermann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90ec4ccebc8847f1bd3715fd4a528a69 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
por: Assad Shiti, et al.
Publicado: (2021) -
Left Ventricular Flow Distribution as a Novel Flow Biomarker in Atrial Fibrillation
por: Hansuk Kim, et al.
Publicado: (2021) -
Left ventricular torsion an echocardiographic prognosticator in dilated cardiomyopathy patients
por: Amit Kumar, et al.
Publicado: (2021) -
Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue
por: Zachary Laksman, et al.
Publicado: (2017) -
Left ventricular systolic dysfunction among nocturnal myocardial infarctions
por: A Ghaemian, et al.
Publicado: (2004)